NCT02313454View on ClinicalTrials.gov

Evaluation of the Safety and Effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator in Patients With Dry Eye

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 17, 2014

Primary Completion Date

April 8, 2015

Study Completion Date

April 8, 2015

Conditions
Dry Eye Syndromes
Interventions
DEVICE

Intranasal Tear Neurostimulator

Neurostimulation applied intranasally and extranasally.

Trial Locations (1)

01810

Andover Eye Associates, Andover

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
collaborator

ORA, Inc.

INDUSTRY

lead

Allergan

INDUSTRY